{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T02:12:44Z","timestamp":1794363164522,"version":"4.9.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Liquids"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.molliq.2022.118901","type":"journal-article","created":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T02:14:07Z","timestamp":1646792047000},"page":"118901","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":305,"special_numbering":"C","title":["Molecular dynamics simulation approach for discovering potential inhibitors against SARS-CoV-2: A structural review"],"prefix":"10.1016","volume":"354","author":[{"given":"Shabnam","family":"Ghahremanian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Mehdi","family":"Rashidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimai","family":"Raeisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davood","family":"Toghraie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.molliq.2022.118901_b0005","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/13543776.2020.1772231","article-title":"SARS, MERS and SARS-CoV-2 (COVID-19) treatment: a patent review","volume":"30","author":"Nascimento Junior","year":"2020","journal-title":"Exp. Opin. Ther. Pat"},{"issue":"6","key":"10.1016\/j.molliq.2022.118901_b0010","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20201256","article-title":"Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: possible implication in COVID-19 therapy","volume":"40","author":"Shamsi","year":"2020","journal-title":"Biosci. Rep"},{"issue":"4","key":"10.1016\/j.molliq.2022.118901_b0015","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s12098-020-03263-6","article-title":"A review of coronavirus disease-2019 (COVID-19)","volume":"87","author":"Singhal","year":"2020","journal-title":"Indian. J. Pediatr"},{"key":"10.1016\/j.molliq.2022.118901_b0020","article-title":"Capacitive Aptasensor Coupled with Microfluidic Enrichment for Real-Time Detection of Trace SARS-CoV-2 Nucleocapsid Protein","author":"Qi","year":"2022","journal-title":"Anal. Chem."},{"key":"10.1016\/j.molliq.2022.118901_b0025","article-title":"A Bionic-Homodimerization Strategy for Optimizing Modulators of Protein-Protein Interactions: From Statistical Mechanics Theory to Potential Clinical Translation","volume":"2105179","author":"Yan","year":"2022","journal-title":"Advanced science"},{"key":"10.1016\/j.molliq.2022.118901_b0030","article-title":"Targeting SARS-CoV-2: a systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 20 -O-ribose methyltransferase","volume":"1\u201314","author":"Khan","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.molliq.2022.118901_b0035","series-title":"How does arbidol inhibit the novel coronavirus SARS-CoV-2? Atomistic Insights from Molecular Dynamics Simulations","author":"Padhi","year":"2020"},{"issue":"8","key":"10.1016\/j.molliq.2022.118901_b0040","doi-asserted-by":"crossref","first-page":"5844","DOI":"10.1021\/acs.nanolett.0c01757","article-title":"Chiral Protein Supraparticles for Tumor Suppression and Synergistic Immunotherapy: An Enabling Strategy for Bioactive Supramolecular Chirality Construction.","volume":"20","author":"Yan","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.molliq.2022.118901_b0045","doi-asserted-by":"crossref","first-page":"117477","DOI":"10.1016\/j.lfs.2020.117477","article-title":"Anti-HCV, nucleotide inhibitors, repurposing against COVID-19","volume":"248","author":"Elfiky","year":"2020","journal-title":"Life Sci."},{"issue":"9","key":"10.1016\/j.molliq.2022.118901_b0050","doi-asserted-by":"crossref","first-page":"e1007296","DOI":"10.1371\/journal.ppat.1007296","article-title":"The papain-like protease determines a virulence trait that varies among members of the SARS- coronavirus species","volume":"14","author":"Niemeyer","year":"2018","journal-title":"PLoS Pathog"},{"issue":"15","key":"10.1016\/j.molliq.2022.118901_b0055","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1021\/bi036022q","article-title":"3C-like proteinase from SARS coronavirus catalyzes substrate hydrolysis by a general base mechanism","volume":"43","author":"Huang","year":"2004","journal-title":"Biochemistry"},{"issue":"18","key":"10.1016\/j.molliq.2022.118901_b0060","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"B, Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.molliq.2022.118901_b0065","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1007\/s10973-020-10353-2","article-title":"Thermal and hydrodynamic properties of coronavirus at various temperature and pressure via molecular dynamics approach","volume":"143","author":"Malekahmadi","year":"2021","journal-title":"J Therm Anal Calorim"},{"issue":"4","key":"10.1016\/j.molliq.2022.118901_b0070","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s40571-020-00367-w","article-title":"Molecular dynamics performance for coronavirus simulation by C, N, O, and S atoms implementation dreiding force field: drug delivery atomic interaction in contact with metallic Fe, Al, and steel","volume":"8","author":"Karimipour","year":"2021","journal-title":"Comp. Part. Mech."},{"key":"10.1016\/j.molliq.2022.118901_b0075","doi-asserted-by":"crossref","first-page":"7653","DOI":"10.1038\/s41598-021-86986-6","article-title":"Cytotoxic T-lymphocyte elicited vaccine against SARS-CoV-2 employing immunoinformatics framework","volume":"11","author":"Kumar","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.molliq.2022.118901_b0080","doi-asserted-by":"crossref","first-page":"100064","DOI":"10.1016\/j.crgsc.2021.100064","article-title":"Click triazole as a linker for drug repurposing against SARs-CoV-2: a greener approach in race to find COVID-19 therapeutic","volume":"4","author":"Chatterjee","year":"2021","journal-title":"Current Research in Green and Sustainable Chemistry"},{"issue":"1","key":"10.1016\/j.molliq.2022.118901_b0085","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/07391102.2020.1808072","article-title":"Antitussive noscapine and antiviral drug conjugates as arsenal against COVID-19: a comprehensive chemoinformatics analysis","volume":"40","author":"Kumar","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"6","key":"10.1016\/j.molliq.2022.118901_b0090","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1021\/acsptsci.0c00139","article-title":"Vaccine formulation and optimization for human herpes virus-5 through an immunoinformatics framework","volume":"3","author":"Kumar","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"59","key":"10.1016\/j.molliq.2022.118901_b0095","doi-asserted-by":"crossref","first-page":"35856","DOI":"10.1039\/D0RA06849G","article-title":"Design and optimization of a subunit vaccine targeting COVID-19 molecular shreds using an immunoinformatics framework","volume":"10","author":"Kumar","year":"2020","journal-title":"RSC Adv."},{"issue":"15","key":"10.1016\/j.molliq.2022.118901_b0100","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1080\/07391102.2019.1682052","article-title":"Virtual high throughput screening of natural compounds in-search of potential inhibitors for protection of telomeres 1 (POT1)","volume":"38","author":"Amir","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"8","key":"10.1016\/j.molliq.2022.118901_b0105","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1080\/07391102.2018.1479310","article-title":"I, High throughput screening, docking, and molecular dynamics studies to identify potential inhibitors of human calcium\/calmodulin-dependent protein kinase IV","volume":"37","author":"Beg","year":"2019","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"40","key":"10.1016\/j.molliq.2022.118901_b0110","doi-asserted-by":"crossref","first-page":"23302","DOI":"10.1039\/C9RA02864A","article-title":"I, Molecular interaction studies on ellagic acid for its anticancer potential targeting pyruvate dehydrogenase kinase 3","volume":"9","author":"Dahiya","year":"2019","journal-title":"RSC Adv."},{"issue":"16","key":"10.1016\/j.molliq.2022.118901_b0115","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1080\/07391102.2018.1546621","article-title":"I, Binding mechanism of caffeic acid and simvastatin to the integrin linked kinase for therapeutic implications: A comparative docking and MD simulation studies","volume":"37","author":"Gulzar","year":"2019","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"1","key":"10.1016\/j.molliq.2022.118901_b0120","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41598-019-55199-3","article-title":"Evaluation of binding and inhibition mechanism of dietary phytochemicals with sphingosine kinase 1: Towards targeted anticancer therapy","volume":"9","author":"Gupta","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molliq.2022.118901_b0125","doi-asserted-by":"crossref","first-page":"109245","DOI":"10.1016\/j.biopha.2019.109245","article-title":"Evaluation of ellagic acid as an inhibitor of sphingosine kinase 1: a targeted approach towards anticancer therapy","volume":"118","author":"Gupta","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.molliq.2022.118901_b0130","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nphys2815","article-title":"Inconsistent thermostatistics and negative absolute temperatures","volume":"10","author":"Dunkel","year":"2014","journal-title":"Nat. Phys."},{"issue":"18","key":"10.1016\/j.molliq.2022.118901_b0135","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.3390\/molecules24183387","article-title":"Molecular docking and dynamics simulation of protein beta-tubulin and antifungal cyclic lipopeptides","volume":"24","author":"Cob-Calan","year":"2019","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.molliq.2022.118901_b0140","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1110\/ps.690101","article-title":"A normalized rootmean-spuare distance for comparing protein three-dimensional structures","volume":"10","author":"Carugo","year":"2001","journal-title":"Protein Sci."},{"issue":"16","key":"10.1016\/j.molliq.2022.118901_b0145","doi-asserted-by":"crossref","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","article-title":"End-point binding free energy calculation with MM\/PBSA and MM\/GBSA: Strategies and applications in drug design","volume":"119","author":"Wang","year":"2019","journal-title":"Chem. Rev."},{"issue":"2","key":"10.1016\/j.molliq.2022.118901_b0150","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3390\/polym11020282","article-title":"Effects of an electric field on the conformational transition of the protein: a molecular dynamics simulation study","volume":"11","author":"Jiang","year":"2019","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.molliq.2022.118901_b0155","doi-asserted-by":"crossref","first-page":"456","DOI":"10.2174\/1389203715666140327114232","article-title":"A review of methods available to estimate solvent-accessible surface areas of soluble proteins in the folded and unfolded states","volume":"15","author":"Ali","year":"2014","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.molliq.2022.118901_b0160","article-title":"Molecular dynamics simulation perception study of the binding affinity performance for main protease of SARS-CoV-2","author":"Narayan Sahu","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.molliq.2022.118901_b0165","article-title":"In-silico screening predicts common cold drug Dextromethorphan along with Prednisolone and Dexamethasone can be effective against novel Coronavirus disease (COVID-19)","author":"Sarkar","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.molliq.2022.118901_b0170","doi-asserted-by":"crossref","unstructured":"Shama Khan Zeynab Fakhar Afzal Hussain Aijaz Ahmad Deeba Shamim Jairajpuri Mohamed F. Alajmi Md. Imtaiyaz Hassan Structure-based identification of potential SARS-CoV-2 main protease inhibitors J. Biomol. Struct. Dyn. 2020","DOI":"10.1080\/07391102.2020.1848634"},{"key":"10.1016\/j.molliq.2022.118901_b0175","article-title":"Structure-based virtual screening and molecular dynamics simulation of SARS-CoV-2 Guanine-N7 methyltransferase (nsp14) for identifying antiviral inhibitors against COVID-19","author":"Selvaraj","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.molliq.2022.118901_b0180","article-title":"Identification of potential molecules against COVID-19 main protease through structure-guided virtual screening approach","author":"Mittal","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.molliq.2022.118901_b0185","article-title":"Virtual screening and molecular simulation study of natural products database for lead identification of novel coronavirus main protease inhibitors","author":"Tripathi","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.molliq.2022.118901_b0190","article-title":"Targeting SARS-CoV-2 main protease: structure based virtual screening, in silico ADMET studies and molecular dynamics simulation for identification of potential inhibitors","author":"Uniyal","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.molliq.2022.118901_b0195","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/biology10010002","article-title":"Drug repurposing approach against novel coronavirus disease (COVID-19) through virtual screening targeting SARS-CoV-2 main protease","volume":"10","author":"Chowdhury","year":"2021","journal-title":"Biology"},{"key":"10.1016\/j.molliq.2022.118901_b0200","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10822-020-00356-4","article-title":"Supervised molecular dynamics for exploring the druggability of the SARS-CoV-2 spike protein","volume":"35","author":"Deganutti","year":"2021","journal-title":"J. Comput. Aid. Mol. Des."},{"key":"10.1016\/j.molliq.2022.118901_b0205","article-title":"Identification of natural inhibitors against prime targets of SARS-CoV-2 using molecular docking, molecular dynamics simulation and MM-PBSA approaches","author":"Sharma","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.molliq.2022.118901_b0210","doi-asserted-by":"crossref","unstructured":"Mubarak A. Alamri, Muhammad Tahir ul Qamar, Muhammad Usman Mirza, Rajendra Bhadane, Safar M. Alqahtani, Iqra Muneer, Matheus Froeyen & Outi M. H. Salo-Ahen, Pharmacoinformatics and molecular dynamics simulation studies reveal potential covalent and FDA-approved inhibitors of SARS-CoV-2 main protease 3CLpro, J. Biomol. Struct. Dyn. (2020).","DOI":"10.1080\/07391102.2020.1782768"},{"key":"10.1016\/j.molliq.2022.118901_b0215","doi-asserted-by":"crossref","unstructured":"Durgesh Kumar, Kamlesh Kumari, Vijay Kumar Vishvakarma, Abhilash Jayaraj, Dhiraj Kumar, Venkatesh Kumar Ramappa, Rajan Patel, Vinod Kumar, Sujata K. Dass, Ramesh Chandra, Prashant Singh, Promising inhibitors of main protease of novel corona virus to prevent the spread of COVID-19 using docking and molecular dynamics simulation, J. Biomol. Struct. Dyn. (2020).","DOI":"10.1080\/07391102.2020.1779131"},{"key":"10.1016\/j.molliq.2022.118901_b0220","doi-asserted-by":"crossref","unstructured":"Pratap Kumar Parida, Dipak Paul, Debamitra Chakravorty, The natural way forward: molecular dynamics simulation analysis of phytochemicals from Indian medicinal plants as potential inhibitors of SARS-CoV-2 targets, Phytother. Res. (2020) 3420-3433.","DOI":"10.1002\/ptr.6868"},{"key":"10.1016\/j.molliq.2022.118901_b0225","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jtbi.2008.07.030","article-title":"Molecular dynamic simulations analysis of ritronavir and lopinavir as SARS-CoV 3CLpro inhibitors","volume":"254","author":"Nukoolkarn","year":"2008","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.molliq.2022.118901_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.129143","article-title":"Molecular dynamics simulation of docking structures of SARS-CoV-2 main protease and HIV protease inhibitors","volume":"1225","author":"Cardoso","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.molliq.2022.118901_bib231","doi-asserted-by":"crossref","first-page":"801328","DOI":"10.3389\/fphar.2021.801328","article-title":"USP14: Structure, Function, and Target Inhibition","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Pharmacol"},{"issue":"5","key":"10.1016\/j.molliq.2022.118901_bib232","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s00204-021-03023-1","article-title":"Prediction of oral hepatotoxic dose of natural products derived from traditional Chinese medicines based on SVM classifier and PBPK modeling","volume":"95","author":"Li","year":"2021","journal-title":"Arch. Toxicol"},{"issue":"2","key":"10.1016\/j.molliq.2022.118901_bib233","doi-asserted-by":"crossref","first-page":"e512","DOI":"10.1111\/aos.14928","article-title":"Multimodal deep learning with feature level fusion for identification of choroidal neovascularization activity in age\u2010related macular degeneration","volume":"100","author":"Jin","year":"2022","journal-title":"Acta Ophthalmol."}],"container-title":["Journal of Molecular Liquids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167732222004391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167732222004391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T01:25:23Z","timestamp":1759109123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167732222004391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":49,"alternative-id":["S0167732222004391"],"URL":"https:\/\/doi.org\/10.1016\/j.molliq.2022.118901","relation":{},"ISSN":["0167-7322"],"issn-type":[{"value":"0167-7322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular dynamics simulation approach for discovering potential inhibitors against SARS-CoV-2: A structural review","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Liquids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molliq.2022.118901","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"118901"}}